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Summary
Growth and regeneration of blood vessels are crucial processes during embryonic development and in adult disease. Members of
the bone morphogenetic protein (BMP) family are growth factors known to play a key role in vascular development. The BMP
pathway is controlled by extracellular BMP modulators such as BMP endothelial cell precursor derived regulator (BMPER),
which we reported previously acts proangiogenically on endothelial cells in a concentration-dependent manner. Here, we explore
the function of other BMP modulators, especially Tsg, on endothelial cell behaviour and compare them to BMPER. In Matrigel
assays, BMP modulators chordin and noggin had no stimulatory effect; however, gremlin and Tsg enhanced human umbilical
vein endothelial cell (HUVEC) sprouting. As the activation dynamics of Tsg were similar to those of BMPER, we further
investigated the proangiogenic effect of Tsg on endothelial cells. Tsg enhanced endothelial cell ingrowth in the mouse Matrigel
plug assay as well as HUVEC sprouting, migration and proliferation in vitro, dependent on Akt, Erk and Smad signalling
pathway activation in a concentration-dependent manner. Surprisingly, silencing of Tsg also increased HUVEC sprouting,
migration and proliferation, which is again associated with Akt, Erk and Smad signalling pathway activation. Furthermore, we
reveal that Tsg and BMPER interfere with each other to enhance proangiogenic events. However, in vivo the presence of Tsg as
well as of BMPER is mandatory for regular development of the zebrafish vasculature. Taken together, our results suggest that
BMPER and Tsg maintain a fine-tuned equilibrium that controls BMP pathway activity and is necessary for vascular cell
homeostasis.
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Introduction
During embryonic development the process of angiogenesis, i.e.
the formation of new blood vessels from pre-existing ones, is
highly important and tightly regulated by a multitude of
signalling pathways (Heinke et al., 2012b; Herbert and Stainier,
2011). Many of the embryonic regulatory pathways have been
found to be recapitulated during adult disease (Martin and
Parkhurst, 2004; Sonnemann and Bement, 2011). Therefore,
understanding embryonic molecular mechanism in angiogenesis
provides further insight for therapeutic approaches under
pathological conditions in the adult such as cancer, retinopathy,
ischemic heart disease, stroke or pre-eclampsia (Carmeliet and
Jain, 2011; Potente et al., 2011).
To generate a complex, intensively branched vasculature,
endothelial cell behaviour has to be fine-tuned by a plethora of
growth factors and signalling cascades to enable several cellular
mechanisms including migration, proliferation and differentiation
(Heinke et al., 2012b; Herbert and Stainier, 2011). For example,
the well-known vascular endothelial growth factor (VEGF)
activates the phosphoinositide 3-kinase (PI3K)/Akt signalling
axis and the mitogen-activated protein kinase (MAPK)/
extracellular signal-regulated kinase (Erk) signalling cascades
that in the following facilitate endothelial cell sprouting and
survival (Muñoz-Chápuli et al., 2004; Olsson et al., 2006;
Shiojima and Walsh, 2002). Besides VEGF, a lot of other
different signalling mediators, such as bone morphogenetic
proteins (BMPs), appear to cooperate in the many steps of
angiogenesis (Adams and Alitalo, 2007; David et al., 2009; ten
Dijke and Arthur, 2007).
BMPs belong to the transforming growth factor-b (TGF-b)
superfamily that have been extensively studied during embryonic
development, in which they control axis formation and
organogenesis (Wagner et al., 2010). BMPs are extracellular
proteins that signal through cell surface complexes of
heterodimeric transmembrane serine/threonine kinase receptors.
Upon intracellular activation of the receptor, Smad 1/5
transcription factors become phosphorylated and therefore
obtain the ability to translocate to the nucleus where they
modulate gene expression (Schmierer and Hill, 2007; Sieber et al.,
2009). Besides this Smad-dependent pathway, we and others
have shown that BMPs phosphorylate other Smad-independent



















(Bragdon et al., 2011; Sieber et al., 2009; Zhou et al., 2007).
Accordingly, a growing body of evidence suggests that BMPs
influence endothelial cell behaviour through activation of Smad-
dependent and Smad-independent pathways and along this line
angiogenesis (David et al., 2009; Moreno-Miralles et al., 2009;
Moya et al., 2012).
BMP signalling is highly regulated at the extracellular space
by BMP modulators such as chordin (Piccolo et al., 1996),
noggin (Smith and Harland, 1992), Drm/gremlin (Stabile et al.,
2007), twisted gastrulation (Tsg) (Oelgeschläger et al., 2000) and
BMP endothelial cell precursor derived regulator (BMPER)
(Moser et al., 2003) (reviewed by Balemans and Van Hul, 2002;
Umulis et al., 2009). BMPER, the vertebrate homologue of
Drosophila crossveinless 2, is a secreted glycoprotein that
contains five cysteine-rich domains followed by a von
Willebrand D domain and a trypsin inhibitor domain and was
originally identified in a screen for differentially expressed
proteins in embryonic endothelial precursor cells (Moser et al.,
2003). Previously, we and others have shown that BMPER may
enhance BMP signalling in a concentration-dependent fashion
(Heinke et al., 2008; Serpe et al., 2008). Lately, BMPER has been
the subject of intensive research in the area of endothelial cell
biology including inflammation (Helbing et al., 2010; Helbing
et al., 2011), atherosclerosis (Pi et al., 2012a), tumour progression
(Heinke et al., 2012a) and angiogenesis (Heinke et al., 2008;
Moreno-Miralles et al., 2011). However, little is known about the
role of BMP modulators chordin, noggin or Tsg in angiogenesis
(David et al., 2009). As member of the BMP family Tsg contains
the characteristic cysteine-rich domains that enable interaction
between Tsg, BMPs and chordin (Yamamoto and Oelgeschläger,
2004). Similar to BMPER Tsg is reported to exert either pro- or
anti-BMP effects depending on the examined model organism,
developmental stage, organ or tissue (Chang et al., 2001; Little
and Mullins, 2004; Nosaka et al., 2003; Oelgeschläger et al.,
2000; Ross et al., 2001; Scott et al., 2001; Xie and Fisher, 2005;
Zakin and De Robertis, 2004). Interestingly, recent studies in
mice showed a genetic interaction between BMPER and Tsg in
skeletal and nephron development indicating that they cooperate
in fine-tuning BMP signalling (Ikeya et al., 2010; Ikeya et al.,
2008; Zakin et al., 2008).
In this study we aimed to analyse and compare BMP
modulators noggin, chordin, gremlin and Tsg in their ability to
influence endothelial cell function in angiogenesis. We observed
that BMP modulators chordin and noggin had no stimulatory
effect, but gremlin and Tsg enhanced endothelial cell sprouting.
Since gremlin has been investigated recently (Mitola et al., 2010;
Stabile et al., 2007), we focused our interest on Tsg, which had
the same activation dynamics of endothelial cell function as
BMPER. Furthermore, we revealed interference between Tsg and
BMPER to enhance proangiogenic events. However, in vivo the
presence of Tsg as well as BMPER is mandatory for normal
development of the zebrafish (Danio rerio) vasculature.
Results
Extracellular BMP modulators differently affect endothelial
cell sprouting
In our previous work we reported BMPER to act
proangiogenically on endothelial cells in a concentration-
dependent manner (Heinke et al., 2008). In the present study,
we aimed to investigate whether other known BMP modulators
have similar effects on endothelial cell function. Therefore, we
performed tube formation assays, and analysed different
concentrations of BMP modulators chordin, noggin, gremlin
and Tsg (Fig. 1). BMP modulators chordin and noggin had no
stimulatory effect on HUVEC sprouting (Fig. 1A,C), formation
of branch points (Fig. 1B,D), or transmigration through a
modified Boyden chamber system (supplementary material Fig.
S1). In contrast, high concentrations of chordin decreased
HUVEC tube formation and transmigration to 79% compared
to control conditions. Similar to the described concentration-
dependent effect of BMPER gremlin and Tsg enhanced HUVEC
sprouting by up to 57.4% (Fig. 1E) and 85.4% (Fig. 1G),
respectively. Consistently, similar results are obtained by
quantifying the number of branch points (Fig. 1F,H). Very
recently, the angiogenic effect of gremlin has been investigated
in detail by Presta’s group (Mitola et al., 2010; Stabile et al.,
2007). For this reason we focused our further research interest on
the impact of Tsg on endothelial cell function.
Tsg stimulates endothelial cell migration, proliferation
and sprouting
The in vitro Matrigel assay is a quick and easy method to
investigate angiogenic endothelial cell behaviour such as
reorganization of cytoskeleton and to search for cell–cell contact
and cell fusion (Khoo et al., 2011; Ponce, 2009). Since we wanted
to strengthen our basic findings on the Matrigel tube formation
assay as a readout for angiogenic activity, we performed other in
vitro angiogenesis assays such as transmigration, proliferation and
spheroid sprouting assays. The effect of Tsg on endothelial cell
migration was investigated by using a modified Boyden chamber
system (Fig. 2A). To examine HUVEC proliferation a BrdU-based
ELISA was used (Fig. 2B). In both assays Tsg increased
endothelial cell migration and proliferation in a concentration-
dependent manner. Similar to the results obtained from the tube
formation assay (Fig. 1G,H) stimulation of HUVECs with Tsg in
migration and proliferation assays resulted in a graph with a bell-
shaped curve. For 3D spheroid sprouting into a collagen matrix
stimulation of HUVECs with low concentrations of Tsg had no
effect, however at concentrations above 50 ng/ml sprout formation
was significantly enhanced (Fig. 2C–E). Altogether, in vitro
application of Tsg in several functional endothelial cell culture
assays displayed a concentration-dependent proangiogenic effect.
Tsg stimulates in vivo endothelial cell ingrowth in the
mouse Matrigel plug assay
To confirm our in vitro results that Tsg enhances endothelial cell
sprouting, proliferation and migration in vivo we performed
the mouse Matrigel plug assay (Fig. 3). Mice were injected
subcutaneously with Matrigel alone or different concentrations of
Tsg, sacrificed after 10 days and Matrigel plugs were embedded
in paraffin. Application of Tsg increased the amount of
ingrowing endothelial cells compared to unstimulated control
plugs (Fig. 3A). To verify endothelial cell specificity a CD31–
Cy3 staining was performed that shows that the cellular ingrowth
into the Matrigel plug consists mainly of endothelial cells as the
majority of cells (nuclei stained blue) express the endothelial cell
marker CD31 (stained in red) (supplementary material Fig. S2).
Interestingly, quantification of mouse Matrigel plugs again
revealed a bell-shaped curve of endothelial cell ingrowth in
response to increasing concentrations of Tsg, indicating a
complex mechanism by which Tsg regulates angiogenic
processes (Fig. 3B). Taken together, these findings are


















consistent with our in vitro experiments and support the notion
that Tsg has proangiogenic capacity and modulates endothelial
cell function in a concentration-dependent manner.
Tsg induces intracellular signalling pathways necessary
for endothelial cell sprouting
To investigate Tsg signalling pathways in endothelial cells we
analysed Akt, Erk and Smad signalling cascades (Fig. 4A,B),
because they have been implicated in angiogenic processes
(Moya et al., 2012; Muñoz-Chápuli et al., 2004; Shiojima and
Walsh, 2002). Indeed, stimulation of HUVECs with 10 to 20 ng/
ml Tsg protein increased Akt 1/2, Erk 1/2 and Smad 1/5 pathway
activation (Fig. 4A and supplementary material Fig. S3A–C).
Time course experiments revealed that after 5 minutes of Tsg
exposure all three signalling cascades are activated, however only
Akt 1/2 and Erk 1/2 phosphorylation persisted over time in
different intensities (Fig. 4B and supplementary material Fig.
S3D–F). To determine the impact of each signalling pathway on
Tsg-induced endothelial cell sprouting, tube formation assays
with pathway-specific inhibition were performed (Fig. 4C,E,G
and supplementary material Fig. S4). First of all we ascertained
concentrations for Erk inhibitors PD98059, U0126 and Akt
inhibitor Akti VIII, which have a weak to none inhibitory effect
compared to control conditions (data not shown). However,
addition of inhibitors to Tsg-treated HUVECs prevented
enhanced sprouting (Fig. 4C,E) and formation of branch points
(supplementary material Fig. S4A,B). Western blot analysis of
Tsg stimulated HUVECs with Erk 1/2 and Akt 1/2 pathway
inhibitors confirmed specific pathway inhibition (Fig. 4D,F).
Furthermore, we observed that inhibition of Erk with PD98059 or
U0126 increased Akt and Smad1/5 phosphorylation in parts
conferred by total Smad protein stabilization (Fig. 4D).
Fig. 1. Extracellular BMP modulators have
different effects on endothelial cell sprouting in the
tube formation assay. Serum-starved HUVECs were
untreated or treated with bFGF (50 ng/ml) as a
positive control, or with extracellular BMP modulators
at the indicated concentrations, for 16–18 hours before
they were seeded onto Matrigel with 2% FBS medium.
Cumulative sprout length of capillary-like structures
was measured after 3 hours. (A) Chordin, (C) noggin,
(E) gremlin and (G) Tsg. In addition, the number of
branch points was quantified for (B) chordin,
(D) noggin, (F) gremlin and (H) Tsg. Values are
means 6 s.e.m.; n53; *P,0.05 versus control.


















To ascertain if the observed Tsg effects are BMP dependent,
BMP receptor II (BMPRII) expression was targeted with specific
siRNAs. BMPRII knockdown efficacy was quantified by real-
time PCR (supplementary material Fig. S4C). Indeed, deletion
of BMPRII prevented Tsg-treated HUVECs from
enhanced sprouting (Fig. 4G) and formation of branch points
(supplementary material Fig. S4D). Of interest, in BMPRII
siRNA treated cells Akt phosphorylation is increased, whereas
Smad and Erk phosphorylation are unchanged (Fig. 4H).
Stimulation with Tsg had no effect on BMPRII deficient cells,
indicating a BMP pathway dependent effect of Tsg to stimulate
intracellular signalling cascades. Together these data demonstrate
that Tsg activates the Akt, Erk and Smad 1/5 signalling cascades,
which have to act in concert to facilitate endothelial cell
sprouting.
Simultaneous application of Tsg and BMPER abolishes
proangiogenic effects
Recently, mouse genetic experiments revealed interactions of Tsg
and BMPER during bone and kidney development (Ikeya et al.,
2010; Ikeya et al., 2008; Zakin et al., 2008). Moreover,
immunoprecipitation experiments showed a direct physical
interaction between Tsg and BMPER (Ambrosio et al., 2008).
Since Tsg displayed a similar concentration-dependent effect on
endothelial cell sprouting as BMPER (Heinke et al., 2008) we
next aimed to investigate combinatory effects of both in the tube
Fig. 2. Tsg protein stimulates endothelial cell
migration, proliferation and collagen gel spheroid
sprouting. (A) For transmigration experiments
HUVECs were serum-starved overnight and assayed
with Tsg at the indicated concentrations or VEGF
(100 ng/ml final concentration) as positive control, in
migration medium containing 0.5% FBS. Triplicate
samples were fixed after 4 hours and measurements
were made on five random microscopic fields. Values
are means 6 s.e.m.; n53; *P,0.05 versus control. Hpf,
high power field. (B) Proliferation was determined by a
BrdU assay. Triplicate samples of HUVECs were
incubated for 24 hours with BrdU and increasing
concentrations of Tsg, or VEGF (100 ng/ml final
concentration) as positive control, in medium containing
1% FBS. Cells in medium with BrdU only served as a
negative control. Values are means 6 s.e.m.; n54;
*P,0.01 versus control. (C–E) HUVEC spheroids were
embedded in collagen gel containing 10% FBS and
stimulated for 24 hours with or without Tsg at the
indicated concentrations, or with VEGF (50 ng/ml final
concentration) as positive control. Representative
spheroids incubated without (C) or with Tsg (D) are
shown. Scale bars: 200 mm. (E) Quantitative analysis of
cumulative sprout length of spheroids. Values are means
6 s.e.m.; n53; *5P,0.01 versus control.
Fig. 3. Recombinant Tsg protein stimulates endothelial cell
ingrowth in the mouse Matrigel plug assay. Matrigel containing
recombinant Tsg protein was injected subcutaneously into C57BL/6
mice. Matrigel plugs were harvested 10 days after implantation, fixed,
sectioned and stained. (A) Representative micrographs of Matrigel
plugs stained with H&E. Scale bars: 200 mm. (B) Quantification of
endothelial cells in Matrigel plugs with the indicated concentrations of
recombinant Tsg protein. Values are means 6 s.e.m.; n53;
*5P,0.05 versus control.


















formation assay in vitro and in the mouse Matrigel plug assay in
vivo (Fig. 5). First we used the optimal concentration of Tsg to
stimulate HUVEC sprout formation in the tube formation assay
in vitro and added BMPER in equimolar amounts (Fig. 5A–C).
Application of BMPER and Tsg together prevented enhanced
endothelial cell sprouting and branch point formation compared
to Tsg alone, whereas at this high BMPER concentration
endothelial cell sprouting was not affected. We confirmed these
findings by analysis of intracellular signalling cascades
(Fig. 5G). Vice versa, optimal concentrations of BMPER
stimulated HUVEC sprouting and branch point formation and
addition of equimolar amounts of Tsg, which at this
concentration is below a stimulatory effect, inhibited the
proangiogenic BMPER effect (Fig. 5D,E). We confirmed our in
vitro findings in vivo with the mouse Matrigel plug assay
(Fig. 5F). Again, co-stimulation with Tsg and BMPER abolished
increased endothelial cell ingrowth compared to single protein
application. Thus, Tsg and BMPER interfere with each other to
enhance proangiogenic events in endothelial cells.
Tsg and BMPER expression in endothelial cells of
different origin
As we have shown that Tsg and BMPER interact with each other,
we asked if – besides BMPER – Tsg is expressed in endothelial
cells. Indeed, Tsg and BMPER were detectable in human coronary
arterial endothelial cells (HCAECs), venous endothelial cells
(HUVECs) as well as in microvascular endothelial cells (HMECs)
obtained from heart and lung (Fig. 6A–C). Furthermore,
Fig. 4. Recombinant Tsg protein induces
concentration- and time-dependent intracellular
signalling necessary for endothelial cell
sprouting. (A,B) Dose and time dependence of
intracellular signalling by Tsg in HUVECs. Western
blot analyses were performed with the indicated
antibodies. (C,E) Cumulative sprout length of
HUVEC capillary-like structures from tube
formation assays. (C) Tsg-stimulated sprouting was
inhibited when Erk was blocked with signalling
pathway inhibitors PD98059 (20 mM) and U0126
(10 mM) or (E) when Akt signalling was blocked
with Akti VIII (2 mM). Values are means 6 s.e.m.;
n53; *P,0.01 versus control. (D,F) Western blot
analysis of Tsg-stimulated HUVECs with Erk
inhibitors PD98059 (20 mM) and U0126 (10 mM) or
Akt inhibitor Akti VIII (2 mM) were performed with
the indicated antibodies to determine the effects of
inhibition of (D) Erk or (F) Akt phosphorylation on
the other signalling pathways. (G,H) HUVECs were
transfected with either of two BMPRII-specific
siRNAs or scrambled siRNA control. (G) A tube
formation assay was performed 48 hours post-
transfection and cumulative sprout length was
measured. Values are means 6 s.e.m.; n54;
*P,0.01 versus siRNA control. (H) 48 hours post-
transfection cells were lysed and subjected to
western blot analysis performed with the indicated
antibodies. Representative western blots of one of
three independent experiments are shown.


















we confirmed expression and localization of Tsg by
immunocytochemistry in the cytoplasm and at the surface of
HUVECs (Fig. 6D). Taken together, Tsg and BMPER are co-
expressed by primary endothelial cells indicating that they per se
play a role in endothelial cell biology.
Inhibition of Tsg in endothelial cells enhanced sprouting
and signalling
Given that Tsg is expressed in endothelial cells we next aimed to
investigate if loss of Tsg affects endothelial cell function.
Therefore, knockdown efficiencies of two Tsg-specific siRNAs
in HUVECS on mRNA and protein level were validated
(supplementary material Fig. S5A–D). Based on the fact that
stimulation with Tsg increased the angiogenic response we
hypothesized that silencing Tsg would decrease sprouting,
migration and proliferation of endothelial cells. However, the
exact opposite was true: 3D collagen gel spheroid sprouting of
Tsg-depleted HUVECs was increased compared to siRNA
control transfected HUVECs (Fig. 7A,B). Along the same line,
we detected enhanced migration (Fig. 7C) and proliferation
capacity (Fig. 7D) of Tsg-silenced HUVECs. In the mosaic EC
spheroid sprouting assay Tsg-depleted HUVECs (green
fluorescent) formed most of the sprouts compared to equally
mixed numbers of control siRNA-transfected cells (red
fluorescent; Fig. 7E,F). Consistent with a proangiogenic effect,
Tsg-silenced endothelial cells showed enhanced phosphorylation
of Akt, Erk and Smad 1/5 signalling pathways (Fig. 7G). In
summary, both stimulation with Tsg and depletion of Tsg
increased angiogenic function. These data suggest that the
concentration of Tsg is tightly balanced and controlled in
endothelial cells.
Balance of Tsg and BMPER in endothelial cell sprouting
We have shown that Tsg and BMPER block each other in
increasing endothelial cells sprouting in the tube formation assay
(Fig. 5). Here, we asked if stimulation with BMPER affects
HUVEC sprouting when Tsg is silenced (Fig. 8A and
supplementary material Fig. S5E) and vice versa, if stimulation
with Tsg affects HUVEC sprouting when BMPER is silenced
(Fig. 8B and supplementary material Fig. S5F). When Tsg was
silenced HUVEC sprouting and branch point formation was
increased compared to control, however, after additional
Fig. 5. Simultaneous application of Tsg and
BMPER in functional in vitro and in vivo
angiogenesis assays abolishes induction of
proangiogenic effects. (A–C) Tsg-stimulated
HUVEC sprouting was inhibited when
recombinant BMPER protein was added in
equal amounts. (A) HUVECs were incubated
with the indicated proteins and subjected to a
tube formation assay. Representative
micrographs of control, Tsg, BMPER and Tsg
+ BMPER simultaneous application are shown.
Scale bars: 200 mm. (B) Quantification of
cumulative sprout length of capillary-like
structures. (C) Number of branch points.
(D,E) BMPER-stimulated HUVEC sprouting
was inhibited when recombinant Tsg protein
was added in equal amounts. (D) Quantification
of cumulative sprout length of capillary-like
structures. (E) Number of branch points. Values
are means 6 s.e.m.; n53; *P,0.001 versus
control. (F) Quantification of mouse Matrigel
plug assay with the indicated concentrations of
recombinant Tsg and BMPER protein. Values
are means 6 s.e.m.; n53. (G) Western blot
analysis of HUVECs stimulated with BMPER,
Tsg and the combination of BMPER + Tsg
(concentration50.9 nM) performed with the
indicated antibodies. Representative western
blots of one of three independent experiments
are shown.


















stimulation of Tsg-silenced HUVECs with BMPER no change
occurred. On the other hand siRNA control-transfected HUVECs
responded with increased sprouting to BMPER stimulation.
BMPER-silenced HUVECs displayed decreased sprouting on
Matrigel and after additional stimulation of BMPER-silenced
HUVECs with Tsg again no change occurred. Together, these
data indicate that Tsg and BMPER control each other to exert
their angiogenic activity.
BMPER and Tsg are necessary for proper angiogenesis in
zebrafish development
Next we investigated the in vivo relevance of Tsg and BMPER
during development of the vasculature and therefore used the
transgenic fli1:eGFP zebrafish model. In this zebrafish line the
whole vasculature is fluorescent green because of the endothelial-
specific activation of the ETS transcription factor Fli promoter
sequences. We analysed the effect of morpholinos targeted
against Tsg and BMPER on the formation of the intersomitic
vessels (ISV) and caudal vein plexus (CVP) (Fig. 8C–E).
Silencing of Tsg expression by morpholinos caused a large
venous malformation (tail vein ectasia) with blood accumulation
and some ISV defects (Fig. 8C,D). As already published before,
silencing of BMPER resulted in several defects in ISV and
disturbed formation of CVP (Moser et al., 2007) (Fig. 8D).
Of interest, co-injection of Tsg morpholinos and BMPER
morpholinos reduced the number of embryos that develop a tail
vein ectasia (Tsg phenotype) but the number of embryos with
ISV malformations was the same (BMPER phenotype; Fig. 8E).
This observation might indicate that BMPER is epistatic to Tsg.
Taken together the data suggest that the presence of Tsg as well
as BMPER is mandatory for correct development of the vascular
system in zebrafish.
Discussion
Only in recent years have BMPs been recognized to play an
important role in the vasculature. In particular, how the different
members of the BMP family influence endothelial cell function
during processes of angiogenesis is of major interest (David et al.,
2009; Moreno-Miralles et al., 2009; Pi et al., 2012b;
Scharpfenecker et al., 2007; Zhou et al., 2007). Previously, we
reported BMPER to act proangiogenic on endothelial cells in a
concentration-dependent manner (Heinke et al., 2008). Here, we
explore the function of BMP modulators noggin, chordin, gremlin
and Tsg on endothelial cell behaviour and compare them to
BMPER (Fig. 1). BMP modulators chordin and noggin had no
stimulatory effect; however, gremlin and Tsg enhanced endothelial
cell sprouting. As Tsg displayed the same activation dynamics as
BMPER, we further investigated the proangiogenic effect of Tsg
on endothelial cells in detail (Figs 2–4). Tsg enhanced endothelial
cell ingrowth in the mouse Matrigel plug assay as well as HUVEC
sprouting, migration and proliferation in vitro dependent on
Akt, Erk and Smad signalling pathway activation in a strict
concentration-dependent manner. Surprisingly, silencing of Tsg
also increased HUVEC sprouting, migration and proliferation,
which is again consistent with Akt, Erk and Smad signalling
pathway activation (Fig. 7). Furthermore, we reveal that Tsg and
BMPER interfere with each other to enhance proangiogenic events
(Figs 5,6; Fig. 8A,B). However, in vivo the presence of Tsg as well
as BMPER is mandatory for regular development of the zebrafish
vasculature (Fig. 8).
In the past, extracellular regulation of BMPs has been
described to occur only by antagonising proteins such as
chordin and noggin, which inhibit BMP binding to receptors
(Balemans and Van Hul, 2002). However, emerging evidence
indicates that some BMP modulators, such as BMPER, exert both
pro- and anti-BMP function (Moreno-Miralles et al., 2009). The
situation becomes even more complex because some modulators,
such as connective tissue growth factor (CTGF), have been
shown to inhibit BMP signalling on the one hand and to promote
TGF-b signalling on the other (Abreu et al., 2002). Altogether,
these findings led us to examine how different extracellular BMP
modulators affect angiogenic function of endothelial cells. We
determined three different functional groups of modulators. First,
the classical BMP antagonists chordin and noggin that have no or
at least an inhibitory effect on endothelial cell sprouting
(Fig. 1A–D) and migration (supplementary material Fig. S1).
Our results are consistent with reports from developmental
studies on the notochord in which chordin and noggin, through
BMP4 antagonism, led to reduced numbers of blood vessels
(Nimmagadda et al., 2005; Reese et al., 2004). Secondly, we
found BMP antagonist gremlin to exert proangiogenic effects on
HUVECs (Fig. 1E,F), which recently Presta and co-workers
reported to be independent of BMPs, but mediated by interaction
with VEGFR2 (Chiodelli et al., 2011; Stabile et al., 2007). The
Fig. 6. Tsg and BMPER expression in endothelial cells of different origin.
(A–C) Expression of Tsg and BMPER in human coronary artery ECs
(HCAECs), HUVECs and human microvascular ECs (HMECs) from lung and
heart were analysed by (A) RT-PCR, (B) western blot analysis of cell lysates
and (C) supernatants. (D) Localization of Tsg protein by
immunocytochemistry in HUVECs (upper panel). Rat IgG2a was used as
negative control (lower panel). Nuclei were stained with DAPI. Scale bars:
50 mm.


















third group consisted of BMPER and Tsg that activated
angiogenic events in a concentration-dependent manner, which
reached a peak and thereafter, at higher concentrations,
diminished (Fig. 1G,H) (Heinke et al., 2008).
We and others recently discovered that BMPER acts in a
concentration-dependent manner on BMPs and either activates or
inhibits signalling (Heinke et al., 2008; Kelley et al., 2009; Serpe
et al., 2008). Mechanistically, BMPER was shown to bind to
different BMPs, type I BMP receptors and chordin, which
dependent on stoichiometry and cellular context leads to pro- or
anti-BMP effects (Ambrosio et al., 2008; Kelley et al., 2009;
Serpe et al., 2008; Umulis et al., 2009). Of interest, Tsg is
also found to either activate or inhibit BMP signalling (Little
and Mullins, 2004; Xie and Fisher, 2005; Yamamoto and
Oelgeschläger, 2004). Here, we have shown that in endothelial
cells stimulation with Tsg leads to angiogenesis and activation of
Smad, Erk and Akt signalling pathways (Fig. 4). Consistently,
these signalling cascades are well known to induce angiogenic
responses (Moya et al., 2012; Muñoz-Chápuli et al., 2004;
Shiojima and Walsh, 2002). BMPs are present in serum (Herrera
and Inman, 2009) as well as endothelial cells produce and secrete
endogenous BMPs (Heinke et al., 2008). To investigate the effect
of Tsg on angiogenesis we used different experimental
approaches, which contained different concentrations of serum.
For example 2% serum was used for Matrigel tube formation
assays, 0.5% serum for transmigration assays and serum-free
Opti-MEM for stimulation of intracellular signalling cascades.
Although quite different amounts of serum and along this line
BMPs were present in the different assays, the Tsg effect is quite
constant. However, the strength of the effect in the transmigration
assay and the stimulation of intracellular signalling pathways are
not as prominent as compared to the results of Matrigel tube
Fig. 7. Inhibition of Tsg in endothelial cells enhanced
sprouting and signalling pathway activation. HUVECs
were silenced for Tsg with either of two specific siRNAs or
transfected with scrambled siRNA as control. (A,B) Six
hours after siRNA transfection a collagen gel spheroid
sprouting assay was performed. (A) Representative siRNA-
transfected spheroids. Scale bars: 200 mm. (B) Quantitative
analysis of cumulative sprout length of spheroids. Values are
means 6 s.e.m.; n53; *P,0.001 versus siRNA control.
(C) Migration was quantified 48 hours post-transfection of
HUVECs. Values are means 6 s.e.m.; n53; *P,0.05 versus
siRNA control. (D) Proliferation was determined by a BrdU
assay. HUVECs were transfected in triplicate with the
indicated siRNAs. 48 hours post-transfection BrdU ELISA
was performed. Values are means 6 s.e.m.; n53; *P,0.001
versus siRNA control. (E) Mosaic spheroids were generated
by mixing equal amounts of HUVECs transfected with either
siRNA control and labelled with CMPTX (red) or siRNA
targeted against Tsg (or control) and labelled with CFDA-SE
(green). Confocal laser microscopy revealed equally mixed
green and red sprouts under control conditions, whereas in
partially Tsg-silenced spheroids, Tsg-silenced cells
predominantly formed sprouts. Scale bars: 200 mm.
(F) Quantification of mosaic spheroids. (G) 48 hours after
siRNA transfection cells were lysed and subjected to western
blot analysis, performed with the indicated antibodies.


















formation and spheroid assays, which might be explained by the
different serum concentrations – and thus BMP levels – in the
different assays. Of interest, BMPER and BMP4 have been
shown very recently to associate with low density lipoprotein
receptor-related protein 1 (LRP1) and along this line acted
proangiogenic on endothelial cell behaviour (Pi et al., 2012b).
LRP1 is known to recognize more than 30 distinct ligands,
cytoplasmic adaptor proteins and modulates the activity of other
transmembrane receptors such as PDGFR-b or TGF-bR.
Furthermore, LRP1 itself is known to activate Akt and Erk
signalling pathways (Lillis et al., 2008; Muratoglu et al., 2010).
Therefore, it is tempting to speculate that also BMP receptors,
ligands and modulators form complexes with high signalling
activity centres such as LRP1, which would localize the
processing of incoming signals on the cell. Tsg might act in a
similar way as – or interfere with – BMPER to enhance the
angiogenic potential of endothelial cells. Taken together, this is
the first report to determine that Tsg has a concentration-
dependent proangiogenic effect on endothelial cells.
During mouse embryonic development, haemangioblasts
develop in the aorto-gonadal-mesonephric (AGM) region,
which subsequently give rise to endothelial capillary plexi
around the whole embryo (Risau and Flamme, 1995). Of
interest, BMP4, BMPER and Tsg are expressed in the AGM
region indicating their role in endothelial cell biology (Marshall
et al., 2000; Moser et al., 2003; Nosaka et al., 2003). To
strengthen these findings, we confirmed expression of BMPER
and Tsg in a variety of adult endothelial cells (Fig. 6).
Recent studies have demonstrated a physical interaction
between Tsg, BMPER, chordin and BMP4 by
immunoprecipitation (Ambrosio et al., 2008). Furthermore,
genetic mouse models have shown interference between
BMPER and Tsg to mediate BMP effects in the context of
bone and nephron development (Ikeya et al., 2010; Ikeya et al.,
2008; Zakin et al., 2008). In mice single homozygous gene
deletions of Tsg or BMPER alone showed a decrease in
ossification of vertebral bodies, but double deficient mice
exhibited very severe reduction in ossification indicating a
synergistic effect between BMPER and Tsg under these
conditions (Ikeya et al., 2008). In the kidney, BMPER
deficiency alone led to defects with lower nephron numbers,
whereas in Tsg-deficient embryos the kidneys overall resembled
the wild type. Of interest, Tsg and BMPER double-deficient mice
displayed a wild-type phenotype indicating Tsg to be epistatic
over BMPER in this context (Ikeya et al., 2010). During
embryonic development, the kidneys develop by branching
morphogenesis of a tubular system, which is a reoccurring
theme during organ development and also found in lung and
vascular development. Therefore, it is not surprising that similar
molecular mechanism are involved to generate analogous
morphological architecture (Herbert and Stainier, 2011;
Horowitz and Simons, 2008). In our work we show that
BMPER as well as Tsg are expressed in endothelial cells and
that single application of recombinant BMPER or Tsg stimulate
proangiogenic behaviour of endothelial cells (Figs 5, 6). This
suggests that addition of certain concentrations of BMPER or Tsg
to existent, endogenous complexes of BMP ligands and
extracellular modulators such as chordin, BMPER and Tsg can
evoke peak BMP signalling (Bier, 2008; Umulis et al., 2009).
However, simultaneous application of equimolar concentrations
of recombinant BMPER and Tsg abrogated the proangiogenic
effect indicating that both proteins predominantly bind and
therefore block each other to interact with endogenous BMP
complexes in the extracellular matrix of endothelial cells. Along
the same line, we hypothesize that after Tsg knockdown in
endothelial cells the observed proangiogenic effect mimics the
application of recombinant BMPER protein, because the balance
between Tsg and BMPER shifted to more BMPER (Fig. 7). Our
hypothesis is underlined by our finding that further addition of
recombinant BMPER protein to Tsg-deficient endothelial cells
led to no further increase in sprouting (Fig. 8A). Taken together,
these data indicate that the concentrations of Tsg and BMPER
have to be tightly balanced to enhance BMP signalling and along
this line endothelial cell sprouting.
Previous in vivo experiments with Xenopus and zebrafish
embryos have revealed the intriguing complexity of Tsg
concentration- and context-dependent effects. High levels of
Tsg overexpression causes ventralization of embryos, indicative
of pro-BMP effects (Oelgeschläger et al., 2000; Ross et al.,
2001), whereas low levels of Tsg overexpression causes
dorsalization and therefore antagonizes BMP signalling (Chang
et al., 2001; Ross et al., 2001; Xie and Fisher, 2005). On the other
hand, injection of high doses of Tsg morpholino oligonucleotides
(MOs) into zebrafish embryos causes dorsalization, indicating a
pro-BMP effect of Tsg (Little and Mullins, 2004; Xie and Fisher,
2005). In contrast, low doses of Tsg MO causes ventralization
and therewith indicate an anti-BMP-effect of Tsg (Ross et al.,
2001; Xie and Fisher, 2005). Thus, the effect of Tsg seems to be
strictly dependent on concentration. In addition, in zebrafish
injected with low doses of Tsg MO all investigators noticed a
ventral tail vein ectasia, where blood accumulates and the
circulation slows (Little and Mullins, 2004; Xie and Fisher,
2005). Furthermore, Xie and Fisher observed an increase in gata2
expression that is consistent with enhanced BMP signalling and
haematopoiesis (Xie and Fisher, 2005). Moreover, BMP4 was
shown to directly increase gata2 expression and along this line
enhanced haemangioblast, haematopoetic and endothelial cells
generation (Lugus et al., 2007). In our study with the transgenic
zebrafish fli1:eGFP line, we again observed blood accumulation
and the formation of an ectasia in the caudal vein plexus (CVP)
after Tsg MO injection (Fig. 8C–E). We noticed a high density of
green fluorescent endothelial cells in the developing CVP, which
recently was shown to be dependent on BMP signalling (Wiley
et al., 2011). Consistently, our Tsg deficiency data from zebrafish
and HUVECs suggest that under these circumstances reduction of
Tsg expression levels enhanced endothelial cell proliferation and
sprouting by enhanced BMP signalling. On the contrary, BMPER
morphants displayed a loss of CVP formation and in addition
disturbed intersomitic vessel (ISV) growth (see also Moser
et al., 2007) indicating loss of BMP signalling in the developing
CVP. Of interest, in Tsg/BMPER double morphant embryos
we observed less cyst formation compared to Tsg single
morphants, suggesting that the cyst formation is caused by
BMPER and enhanced BMP signalling in the absence of Tsg. In
contrast, the ISV sprouting seems to be independent of Tsg, as in
double morphants the phenotype of single BMPER morphants
persist. This is consistent with our BMPER-depleted HUVEC
Matrigel assays, where in the absence of BMPER Tsg is unable to
induce sprouting. Taken together, in angiogenic events Tsg seems
to be dependent on BMPER, whereas loss of BMPER also
displayed Tsg-independent effects.


















In conclusion, extracellular BMP-binding modulators exert
different effects on endothelial cell function and angiogenesis.
While noggin and chordin had no stimulatory effects, gremlin,
BMPER and Tsg enhanced endothelial cell sprouting. For Tsg we
observed stimulatory effects on endothelial cells in gain- or loss-
of-function experiments that appeared to be dependent on the
interaction with BMPER. However, in vivo the effect of Tsg on
the BMP signalling pathway seems to be highly context and
concentration dependent. Altogether, our data indicate that a fine-
tuned equilibrium of Tsg and BMPER controls BMP pathway
activity, which is necessary for endothelial cell function.
Materials and methods
Cell culture and reagents
Isolation of human umbilical vein endothelial cells (HUVECs) was performed as
previously described (Heinke et al., 2008). HUVECs were cultured in enhanced
endothelial cell growth medium (PELOBiotech GmbH, Martinsried, Germany).
Human coronary artery ECs (HCAEC), heart and lung microvascular ECs
(HMECs) were purchased and cultured in EGM2-MV BulletKit medium from Lonza
(Basel, Switzerland). Recombinant mouse Tsg, human BMPER, mouse chordin, human
noggin, mouse gremlin, human VEGF-165 and human FGF basic 146 aa protein were
reconstituted according to the manufacturer’s protocol (R&D Systems GmbH,
Wiesbaden, Germany). MEK1 inhibitor PD98059 and MEK1/2 inhibitor U0126 (also
called Erk inhibitors) were reconstituted according to the manufacturer’s instructions
(Cell Signaling Technology, Danvers, USA). For cell tracking, CFDA-SE (green) and
CellTrackerTM Red CMPTX were used (Life Technologies, Karlsruhe, Germany).
Tube formation assay
Tube formation assay – or Matrigel sprouting assay – was performed as described
previously (Heinke et al., 2008). Briefly, HUVECs were pre-treated with the indicated
concentration of recombinant proteins in 1% FBS/EBM for 16–18 hours. Duplets of
26104 cells per condition were cultured on Matrigel with 2% FBS (BD Biosciences,
Heidelberg, Germany) for 3 hours at 37 C̊, 5% CO2. Cells were fixed with 4%
paraformaldehyde (PFA) and pictures were taken from four random microscopic fields
at 56magnification using a digitized imaging system. The cumulative sprout length
and the number of branch points were measured with AxioVision Rel. 4.8.
Migration assay
Cell migration assay was performed as previously described (Heinke et al., 2008).
In brief, HUVECs were labelled with 10 mM CFDA-SE (Life Technologies),
harvested by centrifugation, resuspended in migration medium (RPMI with 0.5%
Fig. 8. The BMP modulators BMPER
and Tsg are necessary for proper
angiogenesis in vitro and in zebrafish
development. HUVECs were transfected
with either Tsg- or BMPER-specific
siRNAs, or with scrambled siRNA as a
control. Thereafter, Tsg- or BMPER-
silenced HUVECs were stimulated with
BMPER and Tsg, respectively, and
subjected to the tube formation assay.
(A) Cumulative sprout length of Tsg-
silenced HUVECs stimulated with BMPER
and (B) cumulative sprout length of
BMPER-silenced HUVECs stimulated with
Tsg. Values are means 6 s.e.m.; n53;
*P,0.01 versus siRNA control.
(C–E) Silencing of Tsg in zebrafish
embryos causes malformations during
blood vessel development. (C) Vasculature
morphology of uninjected (top) and
0.125 mM Tsg MO-injected (middle)
tg(fli1:eGFP) fish embryos at 48 hpf with
formation of a large venous malformation
(white arrows). (Bottom) Overall
morphology of Tsg MO-injected zebrafish
at 48 hpf with blood accumulation in the
ventral tail vein ectasia (black arrow).
(D) Formation of the trunk vasculature in
48 hpf tg(fli1:eGFP) fish embryos after
injection of 0.125 mM Tsg or 0.25 mM
BMPER MO or a combination of both. Tsg
morphants displayed ventral tail vein
ectasia (white arrows) and some disruption
of ISVs and the DLAV (asterisks). In
BMPER morphants disruption of ISVs and
DLAV was more pronounced and in
addition loss of the CVP (arrowhead) was
observed. Double morphants displayed the
malformations of both single Tsg/BMPER
morphants. (E) Quantification of vascular
defects in 48 hpf tg(fli1:eGFP) Tsg and
BMPER morphants. CVP, caudal vein
plexus; DLAV, dorsal longitudinal
anastomotic vessel; ISV, intersomitic
vessels; hpf, hours post-fertilisation; MO,
morpholino oligonucleotide.


















FBS, 0.1% BSA), counted and placed in the upper chamber of a modified Boyden
chamber (16105 cells per HTS FluoroBlok 24-well chamber; pore size 8 mm; BD
Biosciences). The chambers were placed in 24-well culture dishes containing
migration medium and indicated recombinant proteins. After incubation for
4 hours at 37 C̊, 5% CO2 the cells were fixed with 4% PFA and migrated cells
were counted manually in five random microscopic fields using a fluorescent
microscope.
Proliferation assay
Proliferation was assessed using a colorimetric BrdU-incorporation ELISA
(Roche, Basel, Switzerland) as described recently (Heinke et al., 2012a). In
brief, 24 hours after siRNA transfection, cells were cultured in fresh BrdU-
containing 1% FBS/EBM medium for another 24 hours. For growth factor
stimulation cells were directly cultured with BrdU-containing medium for
24 hours. The colorimetric ELISA for BrdU quantification was performed
following the manufacturer’s instruction.
HUVEC spheroid sprouting assay
HUVEC spheroid sprouting assay was performed as previously described (Heinke
et al., 2008). For mosaic spheroid sprouting experiments siRNA-transfected
HUVECs were labelled with CFDA-SE (green) or CMPTX (red), respectively and
mixed in equal amounts before hanging drops were generated. Collagen embedded
mosaic spheroids were imaged with an inverted ZEISS LSM 5 Live DUO high
speed confocal microscope at the Life Imaging Center, ZBSA, Freiburg, Germany.
Mouse Matrigel plug assay and immunohistochemistry
Experiments were performed according to the Animals Scientific Procedures Act
of 1986 and local ethics protocols. Mouse Matrigel plug assay was performed as
described previously (Heinke et al., 2008). In brief, Matrigel (BD Biosciences) was
mixed with heparin and recombinant proteins and injected subcutaneously into the
abdominal flanks of female C57BL/6N mice (Charles River, Sulzfeld, Germany).
After 10 days, plugs were isolated, fixed in 4% PFA and sectioned. To determine
endothelial cell specificity slides were stained with anti-CD31 (BD Pharmingen)
and goat anti-rat Cy-3 antibodies (Chemicon International). Blood vessel
infiltration was analysed in 10 random Haematoxylin- and Eosin-stained
sections imaged with Zeiss Axioplan2/Axiovision Rel. 4.8.
Western blot analysis
Western blot analysis was performed as previously described (Heinke et al., 2008).
Primary antibodies were incubated overnight at 4 C̊ in 3% non-fat dried milk/
TBST: anti-mouse Tsg (monoclonal rat ab; 1:1000; R&D Systems); anti-human
BMPER (monoclonal rat ab; 1:3000; R&D Systems); anti-human b-tubulin
(monoclonal mouse ab; 1:3000; R&D Systems); anti-P-Akt1/2, P-Erk1/2, P-
Smad1/5, Erk1/2 and Smad5 (polyclonal rabbit abs; 1:1000; Cell Signaling
Technologies); anti-Gapdh (polyclonal rabbit ab; EnoGene, New York, USA).
Secondary antibodies conjugated to horseradish peroxidase were incubated for
1–2 hours at room temperature in 3% non-fat dried milk/TBST: anti-mouse-HRP
(polyclonal ab, 1:5000; R&D Systems); anti-rabbit-HRP (polyclonal ab, 1:10000,
Thermo Fisher Scientific); anti-rat-HRP (polyclonal ab, 1:5000; Dako).
Visualisation was performed using an ECL system (Amersham Bioscience) and
a digital imaging system (chemiDOC XRS and Image Lab 4.0; Bio-Rad).
RNA interference
BMPRII, Tsg and BMPER siRNAs 1 and 2 were purchased from Life
Technologies, respectively. Scrambled negative control Alexa Fluor 488 was
purchased from Qiagen, Hilden, Germany. For transfection a final concentration of
100 nmol/l siRNA together with Lipofectamine RNAiMAX was used according to
the manufacturer’s protocol (Life Technologies). Transfection efficiency was
confirmed by quantitative real-time (q) PCR. Functional cell culture assays were
performed between 8 and 48 hours post transfection.
siRNA sequences: siTsg 1, forward 59-CGCAUGUUUCCUGGGAGUUACU-
GAU-39, reverse 59-AUCAGUAACUCCCAGGAAACAUGCG-39; siTsg 2,
forward 59-CAUCCUGAUGUUCCUGACAUGGCUU-39, reverse 59-AAGCC-
AUGUCAGGAACAUCAGGAUG-39; siBMPRII 1, forward 59-GCUGUUGUAG-
CACAGAUUUAUGUAA-39, reverse 59-UUACAUAAAUCUGUGCUACAACA-
GC-39; siBMPRII 2, forward 59-GCCUUUGAUGGAACAUGACAACAUU-39,
reverse 59-AAUGUUGUCAUGUUCCAUCAAAGGC-39; siBMPER 1, forward
59-GCACCUUAGUCACAUACCCTT-39, reverse 59-GGGUAUGUGACUAAG-
GUGCTG-39; siBMPER 2, forward 59-GCUGCCUCUUUCGAAGUGATT-39,
reverse 59-UCACUUCGAAAGAGGCAGCTC-39.
Immunocytofluorescence
HUVECs grown on glass coverslips were fixed first with 4% PFA and then
blocked with 10% goat serum for 30 minutes at room temperature. Afterwards
cells were incubated over night at 4 C̊ with the monoclonal Tsg antibody (1:100;
R&D Systems) or with control ratIgG2a (BD Pharmingen, Heidelberg, Germany),
respectively. The staining was completed with goat-anti rat-Cy3 (1:500; Chemicon
International). For visualization of nuclei slides were treated with DAPI (1:30000;
Sigma, Deisenhofen, Germany). All photographs were taken with Zeiss Axioplan2
and analysed with Zeiss Axiovision Rel. 4.8.
RNA extraction and reverse transcription
DNA-free total RNA was extracted from HUVEC, HCAEC, HMEC lung and
HMEC heart using the Aurum RNA Mini Kit (Bio-Rad, Munich, Germany).
Reverse transcriptions were performed with iScript cDNA-Kit applying 1 mg RNA
following the manufacturer’s protocol (Bio-Rad).
Semi-quantitative and real-time PCR
Reverse transcription-PCR (RT-PCR) analysis was performed as described
previously (Heinke et al., 2008).
Quantitative real-time PCR analysis following RNA interference was performed
using IQ SybrGreen 2xSupermix and the iCycler real-time PCR detection system
(Bio-Rad). Quantification was performed using MyiQ lightcycler software (Bio-
Rad). Knockdown efficiency was calculated using the DDCT method (Schmittgen
and Livak, 2008; Wong and Medrano, 2005). The housekeeping gene hRP was
used for internal normalization.
Primer sequences: Tsg, forward primer 59-ACTCTAGCCATCCTGATGTTCC-
39, reverse primer 59-CAACACAGTCACAGCACTCG-39; BMPER, forward
primer 59-AGGACAGTGCTGCCCCAAATG-39, reverse primer 59-TACTGACA-
CGTCCCCTGAAAG-39; BMPRII, forward primer 59-ACCAGAAGTGCTA-
GAAGGAG-39, reverse primer 59-GCCGAGCCTCTGCATCCTGGT-39; hRPII,
forward primer 59-GCACCACGTCCAATGACA T-39, reverse primer 59-GTGC-
GGCTGCTTCCATAA-39.
Fish strains, morpholino and RNA injections
Zebrafish embryos of the tg(fli1:eGFP) line (Lawson and Weinstein, 2002) were
raised (Westerfield, 1995) and staged as described (Kimmel et al., 1995). Fertilized
eggs were kept in 0.36 Danieau’s solution at 28 C̊ with addition of 0.003% 1-
phenyl-2-thiourea (Sigma-Aldrich, Taufkirchen, Germany) at 24 hours post-
fertilisation to suppress pigmentation.
For morpholino oligonucleotide (MO) injections one or two cell stage embryos
were injected with 1 nl of the indicated amounts of MOs and raised at 28 C̊ until
analysed. We used previously described MOs targeted against Tsg (Ross et al., 2001)
and zBMPER MO1 (Moser et al., 2007) (Gene Tools, LLC, Philomath, USA).
Statistical analysis and quantification
Statistical analysis was performed using GraphPad Prism 5.0, La Jolla, USA. Data
are presented as means 6 s.e.m. and comparisons were calculated by Student’s t-
test (two-way, unpaired). All experiments were repeated at least three times in
triplicates. Results were considered statistically significant if P,0.05.
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